Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Sales | 572 | 480 | 30 | 0 | 0 |
| Gross Profit | 572 | 480 | 30 | N/A | N/A |
| Operating Expenses | 24,974 | 3,934 | 1,846 | 0 | 0 |
| Operating Income | -24,402 | -3,454 | -1,816 | N/A | N/A |
| Interest Expense | 18 | 73 | 8 | 0 | 0 |
| Other Income | -984 | -1,749 | 13 | 0 | 0 |
| Pre-tax Income | -25,404 | -5,276 | -1,811 | 0 | 0 |
| Net Income Continuous | -25,404 | -5,276 | -1,811 | N/A | N/A |
| Net Income | $-25,404 | $-5,276 | $-1,811 | $N/A | $N/A |
| EPS Basic Total Ops | -24.60 | -14.40 | -5.00 | N/A | N/A |
| EPS Basic Continuous Ops | -21.80 | -14.36 | -4.97 | N/A | N/A |
| EPS Diluted Total Ops | -24.60 | -14.40 | -5.00 | N/A | N/A |
| EPS Diluted Continuous Ops | -21.80 | -14.36 | -4.97 | N/A | N/A |
| EBITDA(a) | $-24,240 | $-3,408 | $-1,812 | $N/A | $N/A |